Herpes simplex virus type 1 (HSV-1) expresses a unique series of RNA molecules, the latency-associated transcripts or LATs, during latent infection of neuronal tissues. Previous studies by others have described a TATA box-containing latency-active promoter, referred to here as LAP1, located approximately 700 bp upstream of the 5' end of the major 2.0-kb LAT. In this report, transient gene expression assays were employed to identify a second, novel latency-active promoter (LAP2) present within a region downstream of LAP1 and 5' proximal to the major 2.0-kb LAT. In contrast to LAP1, this promoter lacks a TATA box but possesses cis-acting regulatory elements and other features frequently observed within eukaryotic housekeeping gene promoters. Unlike most other HSV promoters, LAP2 was down-regulated by the viral transcriptional activators ICP4 and ICPO. The majority of LAP2-positive regulatory elements were located within sequences from -257 to -58 relative to the 5' end of the 2.0-kb LAT, and the basal promoter mapped within sequences from -14 to +28. RNase protection experiments demonstrated that chimeric LAT-chloramphenicol acetyltransferase transcripts produced in the transient assays initiated at or near the 5' end of the major 2-kb LAT. TnS insertional mutagenesis of the ICP4 regulatory gene determined that down-regulation of LAP2 required the ICP4 transactivating domain and targeted the minimal promoter region as the site of action by ICP4. Replicating recombinant viruses containing a LAP2-lacZ reporter gene cassette in an ectopic site (glycoprotein C locus) were shown to be active in mouse trigeminal ganglia. Taken together, these experiments suggest that the LAT region of the HSV-1 genome contains at least two latency-active promoters which may play different roles in expressing the various LATs. Alternatively, these promoters may comprise a larger promoterregulatory complex which may influence transcription during latency.
Herpes simplex virus type 1 (HSV-1) is a human neurotropic, enveloped virus possessing 152 kb of linear doublestranded DNA encoding more than 70 gene products (63) . Primary HSV infection of the skin or mucosal membranes results in virus entry into the peripheral nervous system (PNS) by infectious particle penetration of axon terminals of sensory neurons (76) . The virus capsids are transported in a retrograde manner to neuronal cell bodies within the sensory ganglion where the viral genomes are released into the nuclei. The genome can either express lytic functions or remain largely quiescent, thereby establishing a state of latency. Under these latter circumstances, the viral genome persists for long periods unless interrupted by induction of the lytic cycle with the subsequent appearance of clinically apparent lesions or asymptomatic shedding of virus at or near the primary site of infection.
During latency, the viral genome persists as a circular episome (47) condensed into a chromatin-like structure (14) and shows a highly restricted and characteristic pattern of viral gene expression (31) . The only transcriptionally active region recognized maps within the inverted repeat sequences flanking the unique long (UL) termini and, thus, this latency gene is diploid. A diverse group of RNAs collectively referred to as latency-associated transcripts or LATs are encoded by this gene (10, 27, 42, 55, 62, 73, 74, 77, 79) . The LATs overlap the ICP0 immediate-early regulatory gene and are transcribed off the opposite DNA stand. Studies of the LATs present in latently infected neurons indicate that they are largely intranuclear and nonpolyadenylated and that some of the RNAs are uncapped (15, 73, 79) . The most abundant or major species is approximately 2 kb in length, although less abundant 1.5-and 1.45-kb species are also detectable and are presumed to be derived from the 2-kb RNA by splicing (11, 49, 73, 78, 79, 82) . The 2-kb LAT has also been observed during lytic infection, but the minor species have only been observed during latency.
The LAT region also codes for an 8.77-kb poly(A)+ transcript found in lytic infection which seems to exist in low abundance in latently infected neurons (15, 17, 89) . It has been suggested that this RNA represents the primary LAT transcript, which is subsequently processed to produce the more stable 2.0-, 1.5-, and 1.45-kb poly(A) -species. The 6-to 7-kb spliced poly(A)+ product of this reaction has not been observed, however. The sequence surrounding the 5' end of these smaller RNAs is similar to that of the mammalian consensus splice donor site. Introduction of this splicing signal and the 3' splice acceptor into a reporter gene cassette resulted in proper splicing and transient gene expression in transfection assays (20) , although it is unknown whether this splice site is used in actual latency. Because the 8.77-kb LAT is difficult to detect in latency, it has been suggested that the readily detected 2-kb LAT is a stable intron processed from the larger, highly unstable poly(A)+ mRNA. It remains difficult, though, to explain the presence and processing of the additional smaller LATs, which are detected solely during latency, since they appear to have identical 5' and 3' termini. Alternatively, these species may arise by usage of different splice donor and acceptor sites.
Several studies have been performed to identify and characterize the promoter responsible for LAT expression. The region immediately upstream of the major 2-kb LAT sequence is devoid of the TATA consensus element generally found about 30 bp upstream of the transcription start site for many eukaryotic genes. The nearest TATA box homology is present almost 700 bp upstream of the 5' end of the major 2-kb LAT. Various reports have documented LAT promoter regulatory elements located upstream and within the region of this TATA box (2, 3, 15, 44, (87) (88) (89) . These include several Spl sites, a CAAT box homology (3) , and a cyclic AMP response (CRE) element (44) , a sequence homologous to the adenovirus MLTF element USF (88) , and a neuronal enhancer region (3) . Furthermore, recombinant virus in which the 3-globin genomic clone was inserted 17 bp downstream of the TATA box produced ,-globin-specific mRNA in latently infected sensory neurons of the PNS (17) , and deletion of this TATA boxcontaining promoter region eliminated LAT expression in latently infected ganglia (15, 17) . Additionally, sequence comparison between HSV-1 and HSV-2 showed that the TATA box promoter region and the 3' end of the 2-kb LAT displayed the highest degree of homology (43) between the two strains, although the high level of 3' end homology could be due to the fact that this sequence is also present within the coding sequence of ICPO. These experiments, together, support the conclusion that the LAT promoter lies within the region containing the TATA box and are consistent with evidence that the major 2-kb LAT results from splicing of this larger transcript. For purposes of discussion, this far upstream promoter will be referred to as the latency-active promoter 1 or LAPI.
Not all the evidence, however, is consonant with a single latency-active promoter located far upstream of the 2-kb LAT sequence. In vivo experiments using a virus in which the 3-galactosidase (lacZ) reporter gene was inserted into the LAT region at position + 137 relative to the 5' end of the major 2-kb LAT showed that this recombinant fails to produce ,B-galactosidase during productive infection, yet it displays a punctate staining pattern within latently infected neurons after X-gal (5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside) staining of mouse trigeminal ganglion (TG) tissue sections (32) . RNase mapping studies demonstrated that the chimeric mRNA initiated near the 5' end of the stable LATs, rather than the expected start site downstream of the LAP1 TATA box. Thus, lacZ expression may be induced by a previously undescribed promoter located more proximal to the 5' end of the 2-kb LAT. Recent characterization of the 5' and 3' ends of the stable LATs (75) showed that the 5' end maps to a G residue one nucleotide removed from the proposed splice donor sequence (CA£i/GTAG) in agreement with the initial RNA mapping work (78) , but in contrast to that seen in other studies (42, 43) , although the variation in accuracy of all these assays allows only for the approximate mapping of the 5' end of the 2-kb LAT. Moreover, the 3' end maps approximately 79 bp upstream from the proposed splice acceptor site (75), a region devoid of a consensus splice acceptor and branch-point signals. This is in contrast to previous mapping studies (15) which place the 3' end of the 2-kb LAT at or near the proposed splice acceptor site. These recent results suggest that the 2.0-, 1.5-, and 1.45-kb LATs may represent bona fide transcripts rather than introns merely being processed from the larger 8.77-kb transcript. Again, if this were the case, a second promoter would need to be present within sequences between LAP1 and the 2-kb LAT 5' terminus.
To explore the possibility that a second latency-active promoter exists upstream of the major LAT, this region was juxtaposed to the chloramphenicol acetyltransferase (CAT) reporter gene and examined for promoter activity in a series of transient gene expression-transfection assays. The results of these experiments confirmed the existence of a second promoter, although it is 5-to 10-fold less active than the LAP1 TATA box-containing promoter. RNase mapping assays showed that the 5' end of the CAT-encoding transcript maps to a position in close proximity to the 5' end of the 2-kb LAT. In contrast to typical HSV lytic gene promoters, this promoter responded negatively to the viral transactivators ICP4 and ICPO. The minimal promoter lacked an obvious TATA box homolog and was up-regulated by GC-rich sequences upstream of the basal promoter. In addition, this promoter was found to be capable of driving lacZ expression after its introduction into the glycoprotein C (gC) locus of both wildtype (KOS) and an ICP4-deficient (d120) mutant. Experiments in neuronal cell cultures showed this promoter to be active in the nonreplicating recombinant in vitro. In mouse sensory ganglia in vivo, the promoter was active in the replicating recombinant in a manner consistent with latency-specific expression. We have designated this novel promoter the latencyactive promoter 2 or LAP2.
MATERIALS AND METHODS
Plasmid construction. This report combines transient gene expression data which were derived in two independent laboratories and, thus, two independent sets of wild-type and deletion mutant promoter constructs are described. One set of LAP2-CAT gene plasmids was engineered at the University of Michigan, and the other was constructed at the National Institutes of Health (NIH).
The Michigan LAT promoter-CAT reporter constructs shown in Fig. 1D (66) , and a battery of restriction endonucleases in combination with BamHI was used to subclone the putative LAP2 region into a plasmid containing a loxP recombination site, pBS65-lox (23, 67) . The pSVOCAT (28) plasmid was modified to include a BglII site 5' of CAT, and the 1.6-kb BglII-BamHI fragment containing the CAT gene linked to the simian virus 40 poly(A) signal was cloned downstream of the engineered BamHI site (position +42) in each promoter test plasmid. Internal deletion mutations were produced by partial digestion of the -597/+42 promoter-CAT construct with the restriction enzyme SmaI (BRL) and then by religation according to the conditions described by the supplier (BRL). The -800/+42 construct was produced by cloning the 203-bp (PstI-BamHI)-CAT construct. A promoterless control plasmid was constructed to contain the 1.6-kb CAT gene cloned into the BamHI site of a pBS65-lox plasmid.
The NIH LAT promoter-CAT reporter gene constructs detailed in Fig. 1E were engineered by cloning restriction fragments representing the LAT region into a background plasmid pCAT (64) containing the CAT reporter gene cloned into the HindIlI site of pGEM-3Z (Promega, Madison, Wis.). The 3' limit of these constructs was the HincII site (position 120300) at +839 relative to the 5' end of the 2.0-kb stable LAT transcript. A majority of the constructs were produced by Bal31 (BRL) digestion (66) of the AvaI-HincII clone ( -197/ +839) that was previously cloned withAvaI. The 5' terminus of each construct contained in the library of clones produced by Bal31 digestion was determined by DNA sequence analysis.
The plasmid CAT reporter constructs containing LAP1 TATA box-containing promoter sequences were produced by cloning specific LAT region restriction fragments into either the pCAT (Promega) background (64) or by insertion into pBS65-lox (23, 67) followed by insertion of CAT as described above for the LAP2-CAT constructs.
Construction of Tn5 insertion mutants. The plasmid pSG1-EK1 (60) containing the ICP4 immediate-early regulatory gene was subjected to TnS mutagenesis as previously described (81) , using the A467::Tn5 carrier phage technique of deBruijn and Lupski (12) . The location of the Tn5 inserts within pSG1-EK1 was confirmed by restriction endonuclease digestion. Two specific insertion mutants (detailed in Fig. 6 ) were used in cotransfection experiments along with the test promoter-CAT constructs.
Transfections and CAT assays. Transfections and CAT assays (displayed in Fig. 1D (29) and a 20% glycerol shock by the method of Shapira et al. (68) . Cell lysates harvested at 48 h posttransfection (h.p.t.) were assayed for CAT activity, and the percent conversion of radiolabeled substrate chloramphenicol to the acetylated products was quantitated and normalized to protein content (Bio-Rad, Richmond, Calif.) (7) as previously described (68) . In addition, CAT activity was normalized to P-galactosidase levels displayed by a lacZ-expressing transfection control plasmid. Ex (36, 81) and screened by dot blot hybridization, using a 32P-labeled lacZ-specific probe as previously described (30) . Virus (35) . The ICP4 deletion mutant d120 (13) and the d120(ICP4-),gC ::LAP2-lacZ recombinant were propagated on E5 cells by the method of DeLuca et al. (13) .
Expression of the lacZ reporter gene from viral recombinants in cell culture. Vero, E5, and B103 cells in 60-mmdiameter dishes were each infected with d120 and d120(ICP4-),gC-::LAP2-lacZ at multiplicities of 0.001 and 0.1. At 2 and 5 days postinfection, ,B-galactosidase activity was detected by X-gal staining. Cell monolayers were fixed with 4% paraformaldehyde for 15 anti-p-galactosidase (Cappel) antisera or fixed in 0.5% glutaraldehyde for X-gal staining as previously described (21, 30, 32) .
RT-PCR analyses. Reverse transcriptase (RT)-PCR assays
were performed with RNA isolated from the TG of SpragueDawley rats infected with dl20(ICP4 -),gC-::LAP2-lacZ at 7 and 21 days postinfection. Male Sprague-Dawley rats (190 to 300 g) were anesthetized with 5% chloral hydrate (intraperitoneally, 0.8 ml/100 g of body weight). Both corneas were scraped with a 30-g needle tip, and 2 ,lI containing 1.8 x 106 PFU of the d120(ICP4-),gC-::LAP2-lacZ recombinant was applied to each cornea. The rats were sacrificed by decapitation at 7 and 21 days postinfection, and the TG were removed and immediately frozen in isopentane at -30°C. Several small slices of the TG were homogenized in TRI Reagent (TRI Reagent kit; Molecular Research Center, Cincinnati, Ohio) by the protocol provided in the kit. This kit allows for the isolation of RNA, DNA, and protein from the same sample. Precipitated RNA was treated with RNase-free DNase I (Boehringer Mannheim) prior to use in PCR. RNA RT-PCR analyses were performed on 500 ng of RNA, using primer pairs for glycoprotein B (gB) (gB primer 1 [5' primer] ATT-CTC-CTC-CGA-CGC-CAT-ATC-CAC-CTT; gB primer 2 [3' primer]
AGA-AAG-CCC-CCA-TTG-GCC-AGG-TAG-T) and Igalactosidase (lacZ primer 1 [5' primer] TTG-CTG-ATT-CGA-GGG-GTT-AAC-CGT-CAC-GAG; lacZ primer 2 [3' primer] ACC-AGA-TGA-TCA-CAC-TGC-GGT-GAT-TAC-GAT) and the Gene Amp RNA PCR kit (Perkin-Elmer Cetus, Norwalk, Conn.), as previously described (21) . Reverse transcription of the samples was carried out using avian myeloblastoma virus RT and oligo(dT) at 42°C for 15 min, 99°C for 5 min, and 5°C for 5 min. Reverse-transcribed samples and RNA samples without reverse transcription (-RT) were used in standard PCRs with the gB or lacZ primer pairs according to the provided protocols. The specific reaction conditions used were: (i) initial denaturation at 95°C for 2 min, (ii) (annealling and extension at 60°C for 1 min and denaturation at 95°C for 1 min) x 35 cycles, and (iii) final extension at 72°C for 10 min. PCR products were run on 5% acrylamide gels and gB-or lacZ-specific bands were detected as previously described (21) . PCRs on viral DNA were performed in a similar manner without reverse transcription, as previously described (21) .
RESULTS
Characterization of a promoter designated LAP2 immediately upstream of the 2.0-kb LAT. Two putative promoter constructs encompassing similar sequences lying upstream and extending into the left-hand portion of the 2.0-kb LAT were juxtaposed to the CAT reporter gene and examined for the ability to transiently express CAT after transfection of Vero cells. One construct was produced at the University of Michigan and spanned a region from -800 to +42 bp relative to the 5' terminus of the 2-kb LAT (Fig. 1D) . The second construct was cloned at the NIH and included sequences from -819 to +839 bp relative to the stable LAT S' end (Fig. 1E ). Both laboratories also engineered a large series of 5' deletions in order to search for regulatory elements which might influence promoter activity in transient CAT gene expression assays. The results of the CAT assays are also presented in panels D and E of Fig. 1 .
In general, there was good agreement between the two independent CAT expression analyses employing similar sets of CAT reporter constructs. Constructs containing the region spanning -597 to -193 all displayed high levels (>20% acetylation) of activity. Both studies showed that progressive deletion between -193 and -14 led to a fairly progressive decrease in promoter activity although one region (-81 to -58) containing a C/T-rich element more sharply reduced promoter activity upon removal, suggesting its importance to transcriptional control. Both studies revealed essentially basal promoter activity with constructs containing the region -44 to -14. Promoter activity was lost completely by deletion of the region up to +28, supporting the existence of a minimal promoter element located between -14 and +28. Some differences were observed near the transcription start site. For example, CAT activity was reduced in the -83 Michigan construct, whereas the -78 NIH construct retained activity, which may be due to the presence of an AP2 site or the absence of the entire C/T element. Both analyses also showed that additional upstream sequences (-800/+42 or -819/+829) that encompass the TATA box, CRE (44) , and USF (88) elements were less active than constructs lacking this region (-597/+42 or -597/+839). Since located within a promoter active in driving CAT expression in similar transfection assays, the upstream promoter or some elements associated with it might be interfering with transcription of the downstream TATA-less promoter.
Some internal deletions were also introduced into the formed with equimolar amounts of the LAP2 reporter plasmid (-597/+42) and plasmids encoding either ICP4 (pSG1-EK1) (60) or ICP0 (pIGA15) (24) (Fig. 4) . The LAP2 reporter construct yielded high levels of CAT activity when transfected into Vero cells (Fig. 4, lane 3) . When LAP2 was placed in the opposite orientation to the CAT reporter gene (+42/-597), CAT activity was not detected above the background levels produced by a promoterless CAT construct (Fig. 4 , lanes 1 and 2, respectively), as was also seen in Fig. 3 . Cotransfection with the ICP4-encoding plasmid resulted in a 50-fold reduction in the activity of the LAP2-CAT construct (Fig. 4, lane 4) . In contrast, ICP4 activates all other HSV early and late promoters except for the large subunit of ribonucleotide reductase (RR1) (85) . Cotransfection of an ICPO-expressing plasmid also produced a repressive effect on LAP2 activity (Fig. 4, lane 5) ; however, the magnitude of the reduction in activity was less than that observed with ICP4. ICPO has previously been shown to be a promiscuous transactivator capable of activating a variety of promoters examined in transient cell culture transfection experiments (19, 25, 50, 51, 54) . Cotransfection with both ICP4-and ICP0-encoding plasmids (Fig. 4, lane 6 ) resulted in levels of CAT equivalent to those seen in cells transfected with the promoterless CAT construct (Fig. 4, (Fig. 4, lane 7) . This result could be due to the action of ICP4 and ICPO or due to the action of other proteins encoded by the virus during acute infection.
Regulation of LAP2 by ICP4. Since the activity of LAP2 was reduced by coexpression of ICP4, further assays were designed to evaluate the unique response of LAP2 to ICP4. Cotransfection assays using LAP2 5' deletion constructs and equimolar amounts of wild-type ICP4 were performed to identify any possible cis elements in LAP2 that were negatively responsive to ICP4. The results of these assays are detailed in Fig. 5 . All three constructs containing various amounts of LAP2 sequence ( -597/+42, -171/+42, and -38/+42) were active alone yet were down-regulated markedly in the presence of ICP4, as previously seen in Fig. 4 . Since the minimal promoter-reporter construct (-38/+42) which contains sequences necessary for LAP2 basal activity (-14/+28) was repressed by ICP4, this minimal promoter sequence probably includes the target for the action(s) of ICP4. It is possible that either ICP4 is binding to this region and preventing initiation of transcription from LAP2 or ICP4 is interacting with transcription factors and thereby making them less accessible to LAP2.
To further evaluate the role of ICP4 in repressing LAP2 activity, cotransfection assays were conducted with wild-type ICP4 and Tn5 insertion mutants of ICP4. Tn5 is a prokaryotic transposable element possessing a kanamycin resistance marker flanked by inverted terminal repeat sequence (12) . Tn5 insertion into DNA sequences encoding a specific polypeptide results in truncation of the corresponding gene product because of the presence of amber translation termination codons located within the transposon termini in all three reading frames. This method has been previously employed to disrupt the 12 Us genes of HSV to examine the role of these open reading frames in the neuropathogenesis of HSV infection in vivo (81) . A panel of Tn5 insertion-truncation mutants of ICP4 was produced, the insertion sites were approximated by analysis of restriction enzyme digest patterns, and their ability to repress the activity of LAP2 was assessed in transient cotransfection assays. For comparison, the ability of the ICP4 Tn5 mutants to transactivate the HSV glycoprotein C (gC) late gene promoter was also evaluated. Both LAP2 and the gC promoter were active in driving the CAT reporter gene (Fig. 6,  lanes 1 and 5, respectively) . However, their responses to wild-type ICP4 and the Tn5 mutants differed. Although wildtype ICP4 was able to further activate the gC promoter (Fig. 6,  lane 6 ), it produced a reduction in activity of the LAP2 construct (Fig. 6, lane 2 ). This result with LAP2 was similar to that obtained in previous assays (Fig. 4 and 5) . The ICP4 Tn5 mutant Tn5#15 failed to repress the activity of LAP2 (Fig. 6 , lane 3) compared with that of wild-type ICP4 (Fig. 6, lane 2) . (80) . Another ICP4 Tn5 mutant, Tn5#23, produced results similar to those found using wild-type ICP4, i.e., repressing LAP2 (Fig. 6, lane 4) and activation of the gC promoter (Fig. 6, lane 8 In vivo activity of LAP2. To examine the activity of LAP2 in vivo, it was necessary to juxtapose LAP2 to the lacZ reporter gene and introduce this promoter-reporter gene cassette into the HSV genome. The -597/+42 LAP2 (PstI-BamHI) construct was selected to drive activity of the lacZ reporter gene because of its high level of activity in transient expression assays. The LAP2-lacZ cassette was then subcloned into a plasmid containing gC flanking sequence in order to introduce it into the viral genome by homologous recombination in marker transfer experiments. By cloning LAP2-lacZ into this gC plasmid, the gC promoter sequences were removed, ensuring that expression of the lacZ reporter gene was controlled by LAP2. This construct was recombined into the genomes of both wild-type KOS and the ICP4-mutant d120 to produce the constructs gC-::LAP2-lacZ and dl20(ICP4-), gC-:: LAP2-lacZ, respectively. Diagrams of the viral constructs and the Southern blots of these recombinants are shown in Fig. 7 .
The d120(ICP4-),gC-::LAP2-lacZ recombinant was used to infect cells in culture to examine the activity of LAP2. Vero cells were examined as well as a rat neuroma cell line (B103). The cells were infected at low multiplicities of infection and stained with X-gal to detect the expression of the lacZ reporter gene. Individual Vero cells stained positive for lacZ at both 2 and 5 days postinfection (Fig. 8A) . When the ICP4-inducible ES cell line (13) (PstI-BamHI; -597/+42) was cloned upstream of the 3-galactosidase (lacZ) reporter gene, producing the plasmid pLAP2-lacZ. A PstIBamHI fragment containing the LAP2-lacZ chimera was cloned into a plasmid, pGC-1, that contains the promoter and coding sequence for the glycoprotein C (gC) late gene in a manner that removed all of the gC promoter. This construct, pgC:LAP2-lacZ, was recombined into the genome of wild-type KOS or d120 (ICP4-) (13) by standard marker transfer (36) to produce the recombinants gC-::LAP2-lacZ and d120(ICP4-),gC-::LAP2-lacZ, respectively. The locations of relevant restriction sites and the various HSV gene products within the XhoI A fragment are shown. Southern blot analysis of the LAP2-lacZ viral recombinants. DNA from the recombinants gC-::LAP2-lacZ and d120(ICP4-),gC-::LAP2-lacZ, as well as from the parental viruses (KOS and d120), was digested with EcoRI (E), SalI (S), or XhoI (X). The DNAs were fractionated on a 1% agarose gel, transferred to nitrocellulose, and hybridized with a probe for the lacZ coding sequence. 32 -labeled lambda DNA digested with HindIII was used as a size standard. The sizes and locations of the expected DNA fragments are also depicted.
(data not shown), consistent with the results of transient cotransfection assays. To determine whether LAP2 was active in neurons, the B103 rat neuroma cell line was also infected with the viral recombinant and positive-staining blue neurons were observed (Fig. 8B) . The negative control parental virus d120 (ICP4-) never produced lacZ-positive-staining blue cells, regardless of which cell type was examined (data not shown).
The in vivo LAP2 activity from the viral genome in neurons of the PNS was evaluated after corneal scarification of A/J strain mice with the gC-::LAP2-lacZ recombinant. This recombinant replicates in standard cell culture yet does not produce blue plaques following X-gal agarose overlay (data not shown). This recombinant was able to replicate in corneal epithelial cells after corneal scarification yet failed to produce lacZ from LAP2 in these cells. The TG of infected animals were removed, sectioned, and stained with X-gal at various times postinoculation. No lacZ-positive-staining neurons were detected between 2 and 5 days postinoculation, a time at which viral lytic gene antigens were detected (data not shown). Previously, another virus recombinant containing the lacZ reporter gene driven by the lytic gC late gene promoter in the US3 gene locus, US3-::pgC-lacZ, was reported to stain positive for 3-galactosidase in TG neurons at 2 to 5 days yet was negative by 7 days postinfection (31) . Infection with the gC-::LAP2-lacZ recombinant did, however, produce lacZpositive-staining TG neurons at 7 days postinoculation, a time at which lytic gene expression ceases. 3-galactosidase-positive neurons displayed a punctate staining pattern within the cytoplasm similar both to that observed in cell culture and to that reported by Ho and Mocarski (32) with a similar virus recombinant. 3-galactosidase-positive neurons were also detected at 150 (Fig. 8C and D) to 300 days postinfection, a time consistent with HSV latent infection. X-gal staining for ,B-galactosidase expression was confirmed by immunohistochemical staining with 3-galactosidase antibody (data not shown).
To confirm that the X-gal staining was the result of LAP2-driven expression of the lacZ reporter gene, sensitive RT-PCR assays were performed on RNA isolated from dl20(ICP4-), gC-::LAP2-lacZ-infected rat TG at 7 and 21 days postinoculation, using a lacZ-specific primer pair which we have previously used in similar in vivo RT-PCR assays (21) . A 324-bp lacZ-specific band was detected using RNA isolated from independent animals at both 1 and 3 weeks (Fig. 9A) , whereas RT-PCR for glycoprotein B (gB) failed to detect a gB-specific message at these times postinfection (Fig. 9A) . In addition, DNA PCR was positive for the presence of the viral genome at 21 days postinfection (data not shown), whereas RNA samples that were not reverse transcribed ( -RT) produced no signal (Fig. 9B) , suggesting that the RNA PCR products did not result from DNA contamination and further confirming the specificity of the signal detected. Together, these data show that LAP2 is active in the context of the viral genome at times consistent with HSV latency. DISCUSSION It is clear from previous work that a TATA box-containing promoter exists approximately 700 bp upstream of the major 2.0-kb LAT (2, 3, 15, 44, (87) (88) (89) . The fact that the LAT can be detected long-term and in increasing abundance within the nucleus of latently infected neurons has promulgated the view that the LATs are very stable and unlikely to be translated into protein. The strongest evidence that the TATA box-containing LAT promoter (LAP1) expresses the major LAT includes the observations that (i) deletion of LAP1 removes the expression of the 2.0-kb LAT (15, 17) and (ii) insertion of a reporter gene downstream of the TATA box results in gene expression during latency, with the loss of LAT (17) . Other evidence argues that a second latency-active promoter may exist which includes reports that (i) the 5' and 3' ends of the stable LATs do not match the predicted 5' and 3' splice junctions (75) and (ii) a reporter gene introduced into the LAT region expressed mRNA with a start site near the 5' end of the major LAT (32) . Taken together it appeared possible that a second latencyactive promoter (LAP2) exists downstream of LAP1.
In this study we evaluated the promoter activity of a region immediately 5' to the stable 2-kb HSV-1 LAT and downstream of the promoter (LAP1) characterized by others (2, 3, 15, 44, (87) (88) (89) to allow maximal expression of the CAT reporter gene (Fig. 1) . This region contains several potential cis elements which may boost LAP2 activity. An Spl site, which we have shown to be capable of binding purified Spl in electrophoretic mobility shift assays (22) exists at approximately -590. In addition, putative AP2 ( -473 to -464) and E2F ( -336 to -325) sites can be found within the region possessing promoter-enhancing activity. The 80-bp region between -257 and -177 is extremely G+C rich (91.1%) compared with the remainder of LAP2 (71%) or the rest of the HSV-1 genome (67%). It remains to be determined whether this region attracts transcription factors. Alternatively, these sequences may alter DNA structure after nucleosome phasing and thereby increase availability of the promoter for transcription.
When both LAP1 and LAP2 sequences were present in the test promoter construct, a reduction in the level of CAT activity was seen. It is possible that promoter interference from LAP1 occurred, blocking expression from the TATA-less LAP2 promoter. If transcripts initiated from the LAP1 promoter, they would contain LAP2 promoter sequence at their 5' ends before entering the CAT coding sequence. The presence of a small open reading frame in the LAP2 region (-442 to -283) might result in early ribosome dissociation from these longer transcripts, thereby resulting in the observed decrease in CAT activity.
The in vitro CAT assays also determined that the basal activity of the TATA-less LAP2 promoter could be attributed to sequences between -14 and +28. (46) and the initiator for the TATA-less porphobilinogen deaminase gene (4) . Confirmation of a LAP2 initiator element will require further study using site-directed mutagenesis. (1, 65, 72) . The C/T-rich sequence motif has been found in these atypical promoters usually 30 to 300 nucleotides upstream of the RNA start sites. Similar polypurine-pyrimidine stretches have been shown to induce nuclease hypersensitivity and have the potential to alter chromatin structure. Of interest is the fact that the TATA-less adenovirus IVa2 gene promoter also contains a C/T element (-49 to -42) in addition to possessing an initiator element with sequence homology to the region responsible for LAP2 basal activity (39) . Electrophoretic mobility shift analysis of this region in the murine Thy-i antigen promoter revealed that Spl and another factor appear to bind to the C/T-rich motif (72). Recent reports have described a protein which binds to this C/T motif present in the c-myc, epidermal growth factor receptor (EGF-R), and HarveyKirsten ras promoters (41) . The cDNA encoding the protein termed nuclease-sensitive element protein-I (NSEP-1) which binds to the C/T sequence in these promoters has been identified and characterized. In addition, this region of the c-myc (40) , EGF-R (38) , and c-Ki-ras (34) promoters has been shown to form DNA triplexes by SI nuclease sensitivity analysis. Preliminary work in the Pittsburgh laboratory has shown that the LAP2 C/T element is capable of binding Spl and an additional factor in mobility shift assays with HeLa and B103 neuroma cell extracts (22) . It is possible that this factor is NSEP-1, and preliminary experiments in collaboration with Alan Kinniburgh at the Rosewell Park Cancer Institute in Buffalo suggest that NSEP-1 can bind to the C/T element in LAP2. Two other groups of investigators have isolated a factor, MAZ (6) or ZF87 (59) , which binds specifically to the GA box sequence (GGGAGGG) within the c-myc and C-2 gene sequences. Since the GA box is directly homologous to the C/T-rich element, NSEP-1, MAZ, and ZF87 may potentially represent the same factor. Finally, another group has isolated a similar factor, PuF, which not only binds to the CIT element in the c-myc promoter (56) but also to the CIT element in the TATA-less adenovirus IVa2 gene promoter (39, 56) . Thus, the C/T-rich sequence which modified latency-active promoter activity in vitro may play a crucial role in latency-active promoter activity in vivo. RNase protection assays were employed to determine the start site of the chimeric LAP2-CAT message produced in the transient transfection assays and to evaluate whether this RNA initiated at or near the 5' end of the 2-kb LAT. A prominent band of approximately 290 bp seen with the antisense probe may be the result of multiple initiation sites within a few bases of one another (Fig. 2) , as frequently detected with TATA-less promoters. The presence of multiple initiation sites could also help to explain the differences found by other laboratories in mapping the 5' end of the 2-kb LAT (15, 42, 43, 75, 78) . The results demonstrated that the 5' end of this chimeric RNA mapped in close proximity to the 5' terminus of the 2-kb LAT and not further upstream within the LAP2 sequence.
Transient assays comparing LAP2 with LAPI ( Fig. 3) (2) , and recent data from our group has shown that an RNA molecule initiates 25 bp downstream from the LAP1 TATA box in the reverse orientation, using a combined in vitro transcription-primer extension assay (69) .
Additional transient assays were performed to examine the response of LAP2 to the known HSV-transactivating gene products ICP4 and ICPO. ICP4 is required for the activation of HSV early and late genes (16, 57) , whereas ICPO appears to be a promiscuous transactivating protein capable of inducing viral and cellular promoters (19, 25, 50, 51, 54) . LAP2 was shown to be repressed by both ICP4 and ICPO (Fig. 4) . LAP1 was previously shown to be negatively regulated by ICP4 (2) and indeed LAP1 possesses an ICP4 binding site near the transcription initiation site of the 8.77-kb transcript which does bind ICP4. ICP4 has been shown to act through the TATA box sequence to activate HSV early and late gene promoters (37) and through specific ICP4 binding sites to repress promoter function (48, 61) . Thus, we attempted to identify the sequence(s) in LAP2 that is responsive to the negative action of ICP4. 5' deletion mutants in cotransfection assays with wild-type ICP4 demonstrated that the effect of ICP4 on LAP2 was mediated by sequences present in the minimal LAP2 (-14 to +28), although this region lacks an ICP4 consensus binding site. Using bacterially encoded purified ICP4, it was shown that ICP4 was unable to bind to either the entire (-597/+42) or minimal (-38/+42) LAP2 sequences (83 6 ). These assays demonstrated that the same domain(s) of ICP4 which is involved in the transactivation of early and late HSV genes such as gC is also involved in the down-regulation of LAP2. Recent work with TATA-less promoters (58) has shown that the same factors which interact with the TATA box (TFIIB and TFIID) may also form a complex at the initiator element. Thus, ICP4 may function to repress LAP2 activity by interacting with these factors. Recent evidence indicates that ICP4 does indeed form a complex with the preinitiation transcription complex factors (68b) .
The activity of LAP2 in the context of the viral genome was examined in cell culture and in the PNS of mice. The fulllength LAP2 sequence (-597/+42) was linked to the lacZ reporter gene and inserted into the ectopic gC locus of the HSV genome of wild-type KOS and the ICP4-variant d120 (13) by marker transfer. The LAP2 promoter was active in B103 rat neuroma cells (Fig. 8) after infection with the ICP4 -recombinant d120(ICP4-),gC-::LAP2-lacZ. However, the replicating virus containing the promoter-lacZ gene cassette gC-::LAP2-lacZ failed to produce lacZ-positive-staining cells.
This result may be explained by the action of both ICP4 and ICP0 on LAP2 during lytic infection. After corneal scarification of mice with the gC-::LAP2-lacZ recombinant, lacZ expression could be detected in the cytoplasm of neurons of the TG from 7 to 300 days postinfection by X-gal staining, consistent with the fact that this lacZ construct does not contain a nuclear localization signal. The pattern of staining was punctiform, similar to that seen by Ho and Mocarski with the recombinant RH142 (32) which contains lacZ inserted into the LAT region 137 nucleotides downstream of the 5' end of the stable 2-kb LAT. The presence of the lacZ gene product was further confirmed using f-galactosidase antibody in immunohistochemical reactions (data not shown). RT-PCR data (Fig. 9 ) also supports the presence of a lacZ transcript driven by LAP2 at times consistent with latent infection. Although these assays demonstrate the presence of the LAP2-driven reporter gene product during latency, they do not address the levels of reporter present. Currently, attempts are being made to map the in vivo start site using RNase protection assays.
Overall, the in vivo data demonstrated that LAP2 is active in the context of the viral genome in cultured neurons and in latently infected animals. In addition, placing the LAP2-lacZ construct into the gC locus demonstrates that this promoterregulatory region can function independently of LAP1 in an ectopic site. In further support of the in vivo activity of LAP2, we have obtained similar X-gal staining and RT-PCR results by using a viral recombinant in which the lacZ reporter gene was cloned into the native LAT locus downstream of LAP2 at +42 relative to the 5' end of the 2-kb LAT (9) .
The results of experiments in this report support the existence of a second novel latency-active promoter, LAP2, which lacks a TATA box. The role of specific cis elements within LAP2, such as the G+C-rich area, the C/T sequence, or the putative initiator element, requires further study. It may be possible that both LAP1 and LAP2 do not represent independent latency-active promoters but are actually part of a single complex promoter-regulatory region. Moreover, the G+C-rich region or the C/T element may be responsible for opening up the LAT region for transcription during latency, a time at which the viral DNA molecule may be largely bound by nucleosomes.
